Search
DE EN
more info

Contact:
Phone:+49 0761 1514 440 Fax:+49 0761 1514 460 Email: info@falkfoundation.org

Falk Gastro Review Journal

Current science, compiled for you from the multitude of scientific publications – this is the Falk Gastro Review Journal.

Dunkel- bis hellblaue Grafik einer Tonspur-Frequenz auf orangem Hintergund.

The latest issues

Edition 4/2025

Edition 3/2025

Edition 2/2025

Find here all FGR publications since mid-2022 selected and reviewed from international medical journals. Click here above to browse the individual quarterly issues or use the filters below or click chronologically through all articles.

All articles

Liver and Bile

Fazirsiran for liver disease associated with alpha-1-antitrypsin deficiency

N Engl J Med. 2022;387(6):514–24

Strnad P, Mandorfer M, Choudhury G, Griffiths W, Trautwein C, Loomba R, Schluep T, Chang T, Yi M, Given BD, Hamilton JC, San Martin J, Teckman JH

Liver and Bile

The association between proton-pump inhibitor exposure and key liver-related outcomes in patients with cirrhosis: A Veterans Affairs Cohort Study

Gastroenterology. 2022;163(1):257–69.e6

Mahmud N, Serper M, Taddei TH, Kaplan DE

Liver and Bile

HCC surveillance improves early detection, curative treatment receipt, and survival in patients with cirrhosis: A meta-analysis

J Hepatol. 2022;77(1):128–39

Singal AG, Zhang E, Narasimman M, Rich NE, Waljee AK, Hoshida Y, Yang JD, Reig M, Cabibbo G, Nahon P, Parikh ND, Marrero JA

Liver and Bile

A randomized controlled trial comparing 20%-albumin to plasmalyte in patients with cirrhosis and sepsis-induced hypotension (ALPS trial)

J Hepatol. 2022;77(3):670–82

Maiwall R, Kumar A, Pasupuleti SSR, Hidam AK, Tevethia H, Kumar G, Sahney A, Mitra LG, Sarin SK

Liver and Bile

Risk factors for decompensation and death following umbilical hernia repair in patients with end-stage liver disease

Eur J Gastroenterol Hepatol. 2022;34(10):1060–6

Malik AK, Varghese C, Pandanaboyana S, Sen G, Robinson S, McPherson S, Dyson J, Manas DM, Masson S, Hammond JS; Newcastle Liver Unit

Liver and Bile

Postvaccination COVID-19 infection is associated with reduced mortality in patients with cirrhosis

Hepatology. 2022;76(1):126–38

John BV, Deng Y, Schwartz KB, Taddei TH, Kaplan DE, Martin P, Chao HH, Dahman B

Liver and Bile

Surveillance for hepatocellular carcinoma with a 3-months interval in “extremely high-risk” patients does not further improve survival

Dig Liver Dis. 2022;54(7):927–36

Pelizzaro F, Peserico G, D’Elia M, Cazzagon N, Russo FP, Vitale A, Giannini EG, Piccinnu M, Rapaccini GL, Di Marco M, Caturelli E, Zoli M, Sacco R, Cabibbo G, Marra F, Mega A, Morisco F, Gasbarrini A, Svegliati-Baroni G, Foschi FG, Olivani A, Masotto A, Nardone G, Raimondo G, Azzaroli F, Vidili G, Oliveri F, Trevisani F, Farinati F; Italian Liver Cancer (ITA.LI.CA) Study Group

Liver and Bile

Microwave ablation versus laparoscopic resection as first-line therapy for solitary 3–5-cm HCC

Hepatology. 2022;76(1):66–77

Wang Z, Liu M, Zhang DZ, Wu SS, Hong ZX, He GB, Yang H, Xiang BD, Li X, Jiang TA, Li K, Tang Z, Huang F, Lu M, Chen JA, Lin YC, Lu X, Wu YQ, Zhang XW, Zhang YF, Cheng C, Ye HL, Wang LT, Zhong HG, Zhong JH, Wang L, Chen M, Liang FF, Chen Y, Xu YS, Yu XL, Cheng ZG, Liu FY, Han ZY, Tang WZ, Yu J, Liang P

Liver and Bile

Past COVID-19 and immunosuppressive regimens affect the long-term response to anti-SARS-CoV-2 vaccination in liver transplant recipients

J Hepatol. 2022;77(1):152–62

Toniutto P, Falleti E, Cmet S, Cussigh A, Veneto L, Bitetto D, Fornasiere E, Fumolo E, Fabris C, Sartor A, Peressutti R, Curcio F, Regattin L, Grillone L